Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4795796
Max Phase: Preclinical
Molecular Formula: C30H58N4O12
Molecular Weight: 666.81
Molecule Type: Unknown
Associated Items:
ID: ALA4795796
Max Phase: Preclinical
Molecular Formula: C30H58N4O12
Molecular Weight: 666.81
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCC(=O)NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C30H58N4O12/c1-2-3-4-5-6-7-8-9-10-11-19(36)34-13-17-22(38)24(40)25(41)30(43-17)46-28-16(32)12-15(31)27(26(28)42)45-29-23(39)20(33)21(37)18(14-35)44-29/h15-18,20-30,35,37-42H,2-14,31-33H2,1H3,(H,34,36)/t15-,16+,17-,18-,20+,21-,22-,23-,24+,25-,26-,27+,28-,29-,30-/m1/s1
Standard InChI Key: BZJGCPWLNFLSKF-JMTDOGIVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 666.81 | Molecular Weight (Monoisotopic): 666.4051 | AlogP: -3.21 | #Rotatable Bonds: 17 |
Polar Surface Area: 285.69 | Molecular Species: BASE | HBA: 15 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.05 | CX Basic pKa: 9.34 | CX LogP: -2.54 | CX LogD: -6.28 |
Aromatic Rings: 0 | Heavy Atoms: 46 | QED Weighted: 0.07 | Np Likeness Score: 0.96 |
1. Subedi YP,Kjellgren A,Roberts P,Montgomery H,Thackeray N,Fiori MC,Altenberg GA,Chang CT. (2020) Amphiphilic aminoglycosides with increased selectivity for inhibition of connexin 43 (Cx43) hemichannels., 203 [PMID:32679454] [10.1016/j.ejmech.2020.112602] |
Source(1):